Condition: Head and Neck Squamous Cell Carcinoma (HNSCC) · Sponsor: Regeneron Pharmaceuticals
This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab compared against cemiplimab combined with placebo (a placebo looks like a treatment but does not contain any real medicine), collectively called "study drugs" in this form. The study is focused on participants with head and neck cancers who have not been previously treated for head and neck cancer that has come back or spread to other parts of the body, referred to as recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). The study is looking at several other research questions, including: * What side effects may happen from taking the study drugs * How much of each study drug is in the blood at different times * Whether the body makes antibodies against the study drug(s) individually (which could make the study drugs less effective or could lead to side effects) * Compatible research to better understand the study drugs and HNSCC
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| University of California Los Angeles | Los Angeles, California, United States | Recruiting |
| Orlando Health | Orlando, Florida, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| St. Elizabeth Healthcare | Edgewood, Kentucky, United States | Recruiting |
| Norton Cancer Institute | Louisville, Kentucky, United States | Recruiting |
| Henry Ford Cancer Institute/Henry Ford Health System | Detroit, Michigan, United States | Recruiting |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Omaha, Nebraska, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Asplundh Cancer Pavilion | Willow Grove, Pennsylvania, United States | Recruiting |
| University of Tennessee Medical Center | Knoxville, Tennessee, United States | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Recruiting |
| Joe Arrington Cancer Research & Treatment Center | Lubbock, Texas, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06769698